A citation-based method for searching scientific literature

Lise M van Wijk, Andreea B Nilas, Harry Vrieling, Maaike P G Vreeswijk. Expert Rev Mol Diagn 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
Ke Cong, Min Peng, Arne Nedergaard Kousholt, Wei Ting C Lee, Silviana Lee, Sumeet Nayak, John Krais, Pamela S VanderVere-Carozza, Katherine S Pawelczak, Jennifer Calvo,[...]. Mol Cell 2021
26
100

ATR-Mediated Global Fork Slowing and Reversal Assist Fork Traverse and Prevent Chromosomal Breakage at DNA Interstrand Cross-Links.
Karun Mutreja, Jana Krietsch, Jeannine Hess, Sebastian Ursich, Matteo Berti, Fabienne K Roessler, Ralph Zellweger, Malay Patra, Gilles Gasser, Massimo Lopes. Cell Rep 2018
63
100

Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.
Kristen E Mengwasser, Richard O Adeyemi, Yumei Leng, Mei Yuk Choi, Connor Clairmont, Alan D D'Andrea, Stephen J Elledge. Mol Cell 2019
80
100

Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4.
Shawna Guillemette, Ryan W Serra, Min Peng, Janelle A Hayes, Panagiotis A Konstantinopoulos, Michael R Green, Sharon B Cantor. Genes Dev 2015
92
100

The CIP2A-TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer.
Salomé Adam, Silvia Emma Rossi, Nathalie Moatti, Mara De Marco Zompit, Yibo Xue, Timothy F Ng, Alejandro Álvarez-Quilón, Jessica Desjardins, Vivek Bhaskaran, Giovanni Martino,[...]. Nat Cancer 2021
3
100

Inhibition of the translesion synthesis polymerase REV1 exploits replication gaps as a cancer vulnerability.
Sumeet Nayak, Jennifer A Calvo, Ke Cong, Min Peng, Emily Berthiaume, Jessica Jackson, Angela M Zaino, Alessandro Vindigni, M Kyle Hadden, Sharon B Cantor. Sci Adv 2020
35
100

HPF1-dependent PARP activation promotes LIG3-XRCC1-mediated backup pathway of Okazaki fragment ligation.
Soichiro Kumamoto, Atsuya Nishiyama, Yoshie Chiba, Ryota Miyashita, Chieko Konishi, Yoshiaki Azuma, Makoto Nakanishi. Nucleic Acids Res 2021
6
100

PARP inhibitors: Synthetic lethality in the clinic.
Christopher J Lord, Alan Ashworth. Science 2017
100

Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein-Protein Interaction.
Vibhavari Sail, Alessandro A Rizzo, Nimrat Chatterjee, Radha C Dash, Zuleyha Ozen, Graham C Walker, Dmitry M Korzhnev, M Kyle Hadden. ACS Chem Biol 2017
34
100


Replication Gaps Underlie BRCA Deficiency and Therapy Response.
Nicholas J Panzarino, John J Krais, Ke Cong, Min Peng, Michelle Mosqueda, Sumeet U Nayak, Samuel M Bond, Jennifer A Calvo, Mihir B Doshi, Matt Bere,[...]. Cancer Res 2021
34
100

Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.
Katharina Schlacher, Nicole Christ, Nicolas Siaud, Akinori Egashira, Hong Wu, Maria Jasin. Cell 2011
754
100

Preservation of lagging strand integrity at sites of stalled replication by Pol α-primase and 9-1-1 complex.
Robin van Schendel, Ron Romeijn, Helena Buijs, Marcel Tijsterman. Sci Adv 2021
5
100

Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells.
Ponnari Gottipati, Barbara Vischioni, Niklas Schultz, Joyce Solomons, Helen E Bryant, Tatjana Djureinovic, Natalia Issaeva, Kate Sleeth, Ricky A Sharma, Thomas Helleday. Cancer Res 2010
158
100

53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks.
Samuel F Bunting, Elsa Callén, Nancy Wong, Hua-Tang Chen, Federica Polato, Amanda Gunn, Anne Bothmer, Niklas Feldhahn, Oscar Fernandez-Capetillo, Liu Cao,[...]. Cell 2010
100

ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells.
Stephanie A Yazinski, Valentine Comaills, Rémi Buisson, Marie-Michelle Genois, Hai Dang Nguyen, Chu Kwen Ho, Tanya Todorova Kwan, Robert Morris, Sam Lauffer, André Nussenzweig,[...]. Genes Dev 2017
198
100

Targeting abnormal DNA repair in therapy-resistant breast cancers.
Lisa A Tobin, Carine Robert, Pratik Nagaria, Saranya Chumsri, William Twaddell, Olga B Ioffe, George E Greco, Angela H Brodie, Alan E Tomkinson, Feyruz V Rassool. Mol Cancer Res 2012
62
100

PARP inhibition impedes the maturation of nascent DNA strands during DNA replication.
Alina Vaitsiankova, Kamila Burdova, Margarita Sobol, Amit Gautam, Oldrich Benada, Hana Hanzlikova, Keith W Caldecott. Nat Struct Mol Biol 2022
1
100

Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers.
Reem Ali, Muslim Alabdullah, Mashael Algethami, Adel Alblihy, Islam Miligy, Ahmed Shoqafi, Katia A Mesquita, Tarek Abdel-Fatah, Stephen Yt Chan, Pei Wen Chiang,[...]. Theranostics 2021
1
100

BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage.
Zhihua Kang, Pan Fu, Allen L Alcivar, Haiqing Fu, Christophe Redon, Tzeh Keong Foo, Yamei Zuo, Caiyong Ye, Ryan Baxley, Advaitha Madireddy,[...]. Nat Commun 2021
4
100

Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments.
Arun Mouli Kolinjivadi, Vincenzo Sannino, Anna De Antoni, Karina Zadorozhny, Mairi Kilkenny, Hervé Técher, Giorgio Baldi, Rong Shen, Alberto Ciccia, Luca Pellegrini,[...]. Mol Cell 2017
172
100

Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps.
Mariana Paes Dias, Vivek Tripathi, Ingrid van der Heijden, Ke Cong, Eleni-Maria Manolika, Jinhyuk Bhin, Ewa Gogola, Panagiotis Galanos, Stefano Annunziato, Cor Lieftink,[...]. Mol Cell 2021
7
100

Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.
Junko Murai, Shar-yin N Huang, Benu Brata Das, Amelie Renaud, Yiping Zhang, James H Doroshow, Jiuping Ji, Shunichi Takeda, Yves Pommier. Cancer Res 2012
100

Rad52 inactivation is synthetically lethal with BRCA2 deficiency.
Zhihui Feng, Shaun P Scott, Wendy Bussen, Girdhar G Sharma, Gongshe Guo, Tej K Pandita, Simon N Powell. Proc Natl Acad Sci U S A 2011
219
100


A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy.
Jessica L Wojtaszek, Nimrat Chatterjee, Javaria Najeeb, Azucena Ramos, Minhee Lee, Ke Bian, Jenny Y Xue, Benjamin A Fenton, Hyeri Park, Deyu Li,[...]. Cell 2019
65
100


CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions.
Michal Zimmermann, Olga Murina, Martin A M Reijns, Angelo Agathanggelou, Rachel Challis, Žygimantė Tarnauskaitė, Morwenna Muir, Adeline Fluteau, Michael Aregger, Andrea McEwan,[...]. Nature 2018
169
100

A biochemical defect in the repair of alkylated DNA in cells from an immunodeficient patient (46BR).
I A Teo, B C Broughton, R S Day, M R James, P Karran, L V Mayne, A R Lehmann. Carcinogenesis 1983
54
100

Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action.
Yves Pommier, Mark J O'Connor, Johann de Bono. Sci Transl Med 2016
337
100


Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cells.
Stephanie Tirman, Annabel Quinet, Matthew Wood, Alice Meroni, Emily Cybulla, Jessica Jackson, Silvia Pegoraro, Antoine Simoneau, Lee Zou, Alessandro Vindigni. Mol Cell 2021
11
100

Opposing Roles of FANCJ and HLTF Protect Forks and Restrain Replication during Stress.
Min Peng, Ke Cong, Nicholas J Panzarino, Sumeet Nayak, Jennifer Calvo, Bin Deng, Lihua Julie Zhu, Monika Morocz, Lili Hegedus, Lajos Haracska,[...]. Cell Rep 2018
36
100

Homology-directed repair protects the replicating genome from metabolic assaults.
Kumar Somyajit, Julian Spies, Fabian Coscia, Ufuk Kirik, Maj-Britt Rask, Ji-Hoon Lee, Kai John Neelsen, Andreas Mund, Lars Juhl Jensen, Tanya T Paull,[...]. Dev Cell 2021
16
100

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
100

HLTF Promotes Fork Reversal, Limiting Replication Stress Resistance and Preventing Multiple Mechanisms of Unrestrained DNA Synthesis.
Gongshi Bai, Chames Kermi, Henriette Stoy, Carl J Schiltz, Julien Bacal, Angela M Zaino, M Kyle Hadden, Brandt F Eichman, Massimo Lopes, Karlene A Cimprich. Mol Cell 2020
46
100

Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate.
Cecilia E Ström, Fredrik Johansson, Mathias Uhlén, Cristina Al-Khalili Szigyarto, Klaus Erixon, Thomas Helleday. Nucleic Acids Res 2011
200
100

PARP Inhibitors: Extending Benefit Beyond BRCA-Mutant Cancers.
Patrick G Pilié, Carl M Gay, Lauren A Byers, Mark J O'Connor, Timothy A Yap. Clin Cancer Res 2019
144
100

Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD.
Graeme Hewitt, Valerie Borel, Sandra Segura-Bayona, Tohru Takaki, Phil Ruis, Roberto Bellelli, Laura C Lehmann, Lucia Sommerova, Aleksandra Vancevska, Antonia Tomas-Loba,[...]. Mol Cell 2021
37
100


High speed of fork progression induces DNA replication stress and genomic instability.
Apolinar Maya-Mendoza, Pavel Moudry, Joanna Maria Merchut-Maya, MyungHee Lee, Robert Strauss, Jiri Bartek. Nature 2018
212
100

Intrinsic coupling of lagging-strand synthesis to chromatin assembly.
Duncan J Smith, Iestyn Whitehouse. Nature 2012
193
100

Rad52/Rad59-dependent recombination as a means to rectify faulty Okazaki fragment processing.
Miju Lee, Chul-Hwan Lee, Annie Albert Demin, Palinda Ruvan Munashingha, Tamir Amangyeld, Buki Kwon, Tim Formosa, Yeon-Soo Seo. J Biol Chem 2014
15
100

Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells.
Ralph Zellweger, Damian Dalcher, Karun Mutreja, Matteo Berti, Jonas A Schmid, Raquel Herrador, Alessandro Vindigni, Massimo Lopes. J Cell Biol 2015
370
100


Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors.
Kasper Fugger, Ilirjana Bajrami, Mariana Silva Dos Santos, Sarah Jane Young, Simone Kunzelmann, Geoff Kelly, Graeme Hewitt, Harshil Patel, Robert Goldstone, Thomas Carell,[...]. Science 2021
20
100

A Selective Small Molecule DNA2 Inhibitor for Sensitization of Human Cancer Cells to Chemotherapy.
Wenpeng Liu, Mian Zhou, Zhengke Li, Hongzhi Li, Piotr Polaczek, Huifang Dai, Qiong Wu, Changwei Liu, Kenneth K Karanja, Vencat Popuri,[...]. EBioMedicine 2016
43
100

The DNA translocase FANCM/MHF promotes replication traverse of DNA interstrand crosslinks.
Jing Huang, Shuo Liu, Marina A Bellani, Arun Kalliat Thazhathveetil, Chen Ling, Johan P de Winter, Yinsheng Wang, Weidong Wang, Michael M Seidman. Mol Cell 2013
133
100

FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination.
Elaine Guo, Yuki Ishii, James Mueller, Anjana Srivatsan, Timothy Gahman, Christopher D Putnam, Jean Y J Wang, Richard D Kolodner. Proc Natl Acad Sci U S A 2020
25
100

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
Jirina Bartkova, Zuzana Horejsí, Karen Koed, Alwin Krämer, Frederic Tort, Karsten Zieger, Per Guldberg, Maxwell Sehested, Jahn M Nesland, Claudia Lukas,[...]. Nature 2005
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.